No definition available.
Granulosa cell carcinoma of ovary, excluding all cancers (controls excluding all cancers)
C3_OVARY_GRANULOSA_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
101 |
4. Check minimum number of eventsNone |
101 |
5. Include endpointsNone |
101 |
6. Filter based on genotype QC (FinnGen only) |
101 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Granulosa cell carcinoma of ovary, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Granulosa cell carcinoma of ovary
- Malignant neoplasm of ovary
- Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)
- malignant neoplasm of female genital organs
- malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 101 | 101 | - |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | - |
| Median age at first event (years) | 55.36 | 55.36 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 96
- Matched controls
- 960
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8620/3-C56.9
ICD-O-3
Adult granulosa cell tumor of ovary of ovary
+∞
138.3
96
*
C56.92
ICD-10 Finland
Malignant ovarian tumor, sex chord stroma derived
+∞
111.2
84
*
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
69.6
43.8
49
14
B01AB10
ATC
tinzaparin; parenteral
39.8
34.1
43
19
JN4BD
NOMESCO Finland
Extensive body CT
42.9
27.8
34
12
128
Kela drug reimbursment
Cancers of female genital organs
+∞
27.4
25
*
JAL31
NOMESCO Finland
Laparoscopic omentectomy
333.2
26.0
25
*
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
22.3
24.2
36
25
B01AB05
ATC
enoxaparin; parenteral
9.5
22.4
61
149
H02AB02
ATC
dexamethasone; systemic
93.8
20.7
22
*
C56.91
ICD-10 Finland
Malignant granulosa cell tumor in ovary
+∞
20.5
19
*
JAL30
NOMESCO Finland
Omentectomy
249.3
20.4
20
*
JAL00
NOMESCO Finland
Biopsy of peritoneum
233.8
19.3
19
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
42.5
19.0
23
7
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
7.5
18.6
70
252
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
14.1
16.1
28
27
LAF01
NOMESCO Finland
Laparoscopic unilateral salpingo-oophorectomy
18.4
15.6
24
17
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
7.6
15.4
41
85
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
15.0
14
*
WX402
NOMESCO Finland
General anaesthesia
8.4
14.9
36
64
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
19.9
14.8
22
14
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
22.0
14.6
21
12
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
87.6
14.0
15
*
LCD01
NOMESCO Finland
Total laparoscopic hysterectomy
25.9
14.0
19
9
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
27.2
13.5
18
8
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
19.8
12.2
18
11
LCD00
NOMESCO Finland
Hysterectomy
11.3
12.1
23
26
JN4AD
NOMESCO Finland
Body CT examination
20.3
11.7
17
10
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
+∞
11.7
11
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
5.4
11.4
40
112
A04AA01
ATC
ondansetron; systemic, rectal
16.9
11.0
17
12
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
122.9
10.6
11
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
10.6
10
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
12.7
10.3
18
17
LCD04
NOMESCO Finland
Laparoscopic hysterectomy
8.9
10.2
22
31
TPH07
NOMESCO Finland
Cathetrisation of artery
11.2
9.2
17
18
ZXE20
NOMESCO Finland
More than three and less than five hours
6.7
8.9
23
43
HA1AA
NOMESCO Finland
X-ray mammography
11.0
8.7
16
17
A03FA01
ATC
metoclopramide; systemic, rectal
4.6
8.6
33
98
ZXE10
NOMESCO Finland
More than one and less than three hours
3.7
8.5
51
225
A04AA02
ATC
granisetron; systemic, transdermal
+∞
8.4
8
*
115
Kela drug reimbursment
Breast cancer
+∞
8.4
8
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
8.4
8
*
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
+∞
8.4
8
*
L02BG04
ATC
letrozole; oral
27.6
7.7
10
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
7.4
7
*
L02BA01
ATC
tamoxifen; oral
+∞
7.4
7
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
7.4
7
*
JEA00
NOMESCO Finland
Appendectomy
7.1
7.2
17
28
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
24.5
6.8
9
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.5
6.8
38
152
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
+∞
6.3
6
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
6.3
6
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
6.3
6
*
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
6.0
6.0
16
31
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
92
0
+∞
124.11
9.5
0.0
ng/l
163.2
—
—
59
0
(4035726)
45
20
39.78
65.27
1.4
1.2
—
—
—
0
0
(4281824)
40
6
108.40
38.43
1.2
1.0
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
31
39
11.03
24.45
1.3
1.8
ug/l
7.4
2.4
0.46
20
28
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
80
356
7.00
16.80
4.7
3.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
60
215
5.41
16.14
2.0
1.9
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
46
166
4.25
11.49
2.9
2.9
%
102.6
97.3
0.72
46
160
(3002256) Pathology report gross observation
29
73
5.17
11.43
1.2
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
67
319
4.27
11.24
2.9
1.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
46
171
4.10
10.93
2.0
1.8
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
14
25
6.34
7.78
1.9
1.6
u/l
38.2
233.1
—
5
6
(3009261) Glucose [Presence] in Urine by Test strip
70
430
3.05
6.34
3.1
3.5
estimate
0.0
0.0
0.49
14
71
(3021601) Nitrite [Presence] in Urine by Test strip
69
427
2.94
6.05
3.5
4.8
estimate
0.0
0.0
0.00
13
71
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
8
6
14.32
5.17
1.0
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
37
178
2.70
5.12
6.3
4.8
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
8
7
12.26
4.87
1.0
2.0
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
22
88
2.92
4.23
3.7
1.7
mmol/l
0.8
0.8
0.14
22
82
(3013650) Neutrophils [#/volume] in Blood by Automated count
65
450
2.25
3.67
10.4
6.1
e9/l
3.5
3.9
1.30
60
404
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
16
59
3.03
3.52
3.8
2.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
38
215
2.23
3.51
1.3
1.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
43
263
2.11
3.22
14.5
7.0
inr
1.2
1.1
0.18
16
79
(3019060) Gas panel - Arterial blood
10
31
3.47
2.86
4.8
4.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
94
817
3.17
2.80
14.3
8.8
ml/min/173m2
81.7
82.5
0.14
84
632
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
15
61
2.71
2.77
1.7
1.6
ml/min/173m2
56.7
68.5
—
7
25
(3000991) Gas panel - Venous blood
11
39
3.04
2.57
12.5
5.8
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
42
273
1.92
2.54
2.4
3.6
e6/l
83.8
94.8
0.08
29
176
(3030467) Casts [#/volume] in Urine by Automated count
32
192
1.98
2.42
2.1
2.7
e6/l
0.4
0.6
0.36
24
137
(36304419) Bacteria [Presence] in Urine
32
193
1.96
2.38
2.1
2.6
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
8
23
3.68
2.32
15.5
6.3
%
1.3
1.3
—
8
23
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
8
23
3.68
2.32
15.4
6.3
%
0.9
0.7
—
8
23
(3014007) Fractional oxyhemoglobin in Arterial blood
8
23
3.68
2.32
15.5
6.4
%
93.0
95.3
—
8
23
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
35
226
1.84
2.10
1.6
1.4
—
—
—
0
0
(3020891) Body temperature
7
20
3.68
2.09
5.0
3.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
37
246
1.80
2.01
2.6
2.9
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
33
213
1.82
1.96
3.8
3.9
estimate
0.0
0.0
0.00
13
73
(3002582) Erythrocytes [#/volume] in Urine
33
213
1.82
1.96
2.0
2.9
e6/l
61.3
25.4
0.48
25
158
(3019550) Sodium [Moles/volume] in Serum or Plasma
96
875
2.96
1.94
17.3
11.1
mmol/l
139.9
140.0
0.04
96
846
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
81
894
0.53
1.64
4.3
4.9
mmol/l
2.7
2.9
0.85
76
827
(3044889) 12 lead EKG panel
69
569
1.67
1.57
3.8
3.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
16
266
0.53
1.55
2.3
3.0
mmol/l
6.9
7.1
0.05
16
212
(40768793) Breast Pathology biopsy report
5
16
3.23
1.45
1.2
1.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
27
380
0.60
1.40
2.3
2.3
nmol/l
81.2
78.5
0.15
27
333
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
93
851
2.17
1.40
12.8
10.0
mg/l
26.5
17.6
1.81
79
613
(3011397) Hemoglobin [Presence] in Urine by Test strip
29
198
1.65
1.38
3.0
3.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
19
115
1.80
1.37
1.6
2.3
e6/l
2.9
1.2
0.68
11
62
(3020682) Albumin/Creatinine [Ratio] in Urine
16
257
0.55
1.36
3.2
3.9
mg/mmol
13.8
4.8
—
10
138
(3021589) Normoblasts [#/volume] in Blood
45
344
1.56
1.34
8.1
7.4
e9/l
0.0
0.0
0.50
38
283
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
11
55
2.12
1.33
1.4
1.8
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
5
18
2.87
1.30
1.6
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
18
2.87
1.30
1.0
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
16
250
0.57
1.22
2.4
3.1
mg/l
4568.8
35.1
—
10
138
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
12
201
0.54
1.16
1.6
1.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
8
41
2.03
1.11
1.8
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
7
32
2.27
1.10
18.6
5.9
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
52
423
1.47
1.10
3.3
3.5
estimate
0.0
0.0
0.00
14
72
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
81
878
0.61
1.07
3.9
4.4
mmol/l
4.8
4.9
0.26
76
820
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
75
824
0.65
1.01
4.4
5.5
mmol/mol
39.7
39.4
0.10
68
774
(3022313) Gas panel - Capillary blood
0
30
0.00
0.99
0.0
4.9
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
11
62
1.87
0.98
5.0
3.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
34
262
1.45
0.92
2.4
2.8
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
6
113
0.50
0.89
1.8
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
12
73
1.73
0.86
1.5
1.5
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
6
31
1.99
0.86
8.3
4.2
mmol/l
22.1
25.2
—
6
31
(3024354) Oxygen [Partial pressure] in Venous blood
8
47
1.76
0.83
2.6
2.4
kpa
4.4
4.6
—
8
47
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
26
335
0.70
0.80
1.5
1.9
pmol/l
85.5
100.0
0.79
11
152
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
0
26
0.00
0.79
0.0
1.1
—
0.0
—
0
26
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
0
26
0.00
0.79
0.0
1.1
—
0.0
—
0
26
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
0
26
0.00
0.79
0.0
1.5
—
7.2
—
0
13
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
0
27
0.00
0.78
0.0
1.1
—
38.8
—
0
27
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
0
27
0.00
0.78
0.0
1.1
—
0.4
—
0
27
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
0
27
0.00
0.78
0.0
1.1
—
0.2
—
0
27
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
6
34
1.81
0.77
3.2
2.6
%
50.1
47.9
—
6
34
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
24
2.14
0.75
1.0
1.3
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
9
57
1.63
0.73
2.6
3.5
kpa
6.5
5.8
—
9
57
(40761535) Cells panel - Urine sediment
9
58
1.60
0.72
3.7
2.8
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
5
93
0.51
0.71
4.4
2.8
g/l
2.3
2.5
—
5
85
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
7
43
1.67
0.68
3.3
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
15
104
1.52
0.67
1.5
2.7
e6/l
6.9
4.5
—
7
53
(40761511) CBC panel - Blood by Automated count
95
908
1.78
0.66
14.7
9.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
40
335
1.32
0.63
3.6
3.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
8
53
1.55
0.60
1.1
1.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
82
867
0.71
0.58
3.9
4.4
mmol/l
5.7
5.8
0.56
76
794
(3012544) pH of Venous blood
9
59
1.58
0.57
1.2
3.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
6
97
0.59
0.55
1.5
1.4
—
—
—
0
0
(3013512) EKG study
19
241
0.74
0.51
3.2
3.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
5
85
0.57
0.47
4.4
3.0
%
14.9
25.2
—
5
75
(3037467) Urinalysis macro (dipstick) panel - Urine
66
608
1.25
0.44
3.7
4.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
12
88
1.41
0.42
1.8
1.4
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
7
102
0.66
0.42
3.4
2.7
umol/l
11.7
15.3
—
7
97
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
16
124
1.34
0.42
2.1
1.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
0
16
0.00
0.41
0.0
1.6
—
3781.4
—
0
11
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
5
34
1.49
0.41
2.6
2.8
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
5
34
1.49
0.41
3.4
1.8
g/l
0.2
0.2
—
5
34
(3011288) Drugs identified in Urine by Screen method
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
5
36
1.41
0.39
3.2
2.2
mmol/l
27.4
25.7
—
5
36
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
5
36
1.41
0.39
3.4
1.7
g/l
1.1
1.2
—
5
36
(3013139) Helicobacter pylori Ag [Presence] in Stool
5
76
0.64
0.37
1.4
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
5
77
0.63
0.37
2.6
1.4
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
6
44
1.39
0.35
3.2
2.5
g/l
134.7
132.0
—
6
44
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
45
1.35
0.34
1.2
1.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
28
241
1.22
0.34
3.0
3.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
7
100
0.68
0.32
1.6
1.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
7
100
0.68
0.32
3.1
1.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
7
54
1.32
0.31
2.9
2.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
11
85
1.33
0.29
1.0
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
57
609
0.85
0.29
3.1
3.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
11
86
1.31
0.27
27.8
14.6
—
1.2
—
0
21
(36660697) Celiac disease serology panel - Serum
6
80
0.73
0.25
1.0
1.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
22
191
1.19
0.24
3.0
2.9
ng/l
964.8
1006.1
0.04
22
155
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
5
37
1.37
0.24
3.6
2.0
%
1.2
1.1
—
5
37
(3023368) Bacteria identified in Blood by Culture
17
144
1.22
0.24
9.5
3.3
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
11
0.00
0.21
0.0
2.1
—
105.5
—
0
11
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
11
0.00
0.21
0.0
2.1
—
3.9
—
0
11
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
0
12
0.00
0.21
0.0
2.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
6
47
1.29
0.21
1.3
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
13
0.00
0.21
0.0
3.6
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
18
206
0.85
0.20
1.2
1.3
u/ml
3.1
9.3
—
8
84
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3015736) pH of Urine
38
351
1.13
0.19
3.1
3.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
17
148
1.18
0.18
1.9
1.8
—
—
—
0
0
(4010399)
7
62
1.14
0.17
1.3
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
17
192
0.86
0.16
5.4
4.3
—
—
—
0
0
(3019225) pH of Specimen
6
78
0.75
0.16
2.3
3.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
83
808
1.15
0.16
17.6
10.9
%
36.9
39.9
1.67
64
612
(3036481) Cortisol [Moles/volume] in Serum or Plasma
9
79
1.15
0.16
1.6
1.6
nmol/l
358.1
355.2
—
9
73
(42870588) Differential panel, method unspecified - Blood
29
268
1.12
0.14
4.6
5.1
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
46
440
1.08
0.11
3.9
5.2
e9/l
0.2
0.2
0.11
41
400
(3000330) Specific gravity of Urine by Test strip
5
44
1.14
0.10
2.8
2.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
10
87
1.17
0.10
1.5
1.7
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
5
47
1.07
0.09
1.0
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
6
56
1.08
0.09
1.3
1.2
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
44
423
1.07
0.08
3.9
5.0
e9/l
0.5
0.5
2.36
39
376
(3007164) IgA [Mass/volume] in Serum or Plasma
18
194
0.91
0.08
1.4
1.3
g/l
2.5
2.3
0.14
12
115
(3019832) Treponema pallidum Ab [Presence] in Serum
8
91
0.87
0.07
1.5
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
8
92
0.86
0.07
2.1
1.9
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
44
427
1.05
0.05
3.9
5.0
e9/l
0.0
0.0
0.14
39
377
(1761868) Lipid panel - Serum or Plasma
34
328
1.06
0.05
2.6
2.8
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
19
201
0.93
0.05
1.3
1.3
iu/ml
15.0
31.5
—
7
71
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
28
290
0.95
0.03
2.9
3.2
ng/l
12.2
17.1
1.40
20
181
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
11
105
1.05
0.00
5.2
4.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(4027681)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(44806420)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
1.9
—
0
5
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(4146454)
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
5
53
0.94
0.00
2.4
4.9
—
0.0
—
0
7
(3044242) Glucose [Moles/volume] in Arterial blood
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
6
64
0.93
0.00
1.3
1.6
e9/l
4.4
4.0
—
6
47
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
7
0.00
0.00
0.0
5.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000492) Spirometry study
7
70
1.00
0.00
1.4
1.2
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
2.2
—
51.3
—
0
5
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
87.7
—
0
6
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.1
—
392.9
—
0
7
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
0
5
0.00
0.00
0.0
3.4
—
8.1
—
0
5
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_OVARY_GRANULOSA_EXALLC – Granulosa cell carcinoma of ovary, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).